Parkinson's disease (PD) pathology is characterized by the loss of dopaminergic neurons of
the nigrostriatal system and accumulation of Lewy bodies (LB) and Lewy neurites (LN) …

Introduction Parkinson's disease (PD) is a progressive neurodegenerative disorder
characterized by the loss of dopaminergic neurons as well as the presence of proteinaceous …

The discovery of the involvement of alpha-synuclein (α-syn) in Parkinson's disease (PD)
pathogenesis has resulted in the development and use of viral vector-mediated α-syn …

Although a causative role of α-synuclein (α-syn) is well established in Parkinson's disease
pathogenesis, available animal models of synucleinopathy do not replicate the full range of …

Alpha-synuclein (α-Syn) is a key protein involved in Parkinson's disease (PD) pathology. PD
is characterized by the loss of dopaminergic neuronal cells in the substantia nigra pars …

Lewy bodies, which are a pathological hallmark of Parkinson's disease, contain insoluble
polymers of alpha‐synuclein (αsyn). Among the different modifications that can promote the …

Parkinson's disease (PD) is a common age-related neurodegenerative disorder
characterized by the loss of dopaminergic neurons in the midbrain. A hallmark of both …

Parkinson's disease (PD) pathology is characterized by the formation of intra-neuronal
inclusions called Lewy bodies, which are comprised of alpha-synuclein (α-syn). Duplication …

Accumulation of α-synuclein (α-syn) leading to the formation of insoluble intracellular
aggregates named Lewy bodies is proposed to have a significant role in Parkinson's …

Parkinson's disease (PD) is a pathological condition characterized by the aggregation and
the resultant presence of intraneuronal inclusions termed Lewy bodies (LBs) and Lewy …